(Q36812680)

16 August 2017

1 reference

title

The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer (English)

1 reference

16 August 2017

Mark L Gonzalgo

1

1 reference

16 August 2017

Ram H Datar

series ordinal

2

1 reference

16 August 2017

Mark P Schoenberg

series ordinal

3

1 reference

16 August 2017

Richard J Cote

series ordinal

4

1 reference

16 August 2017

publication date

1 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

25

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

228-235

1 reference

16 August 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

The fundamental role of epigenetic events in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Mutagenic and epigenetic effects of DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Altered DNA methylation and genome instability: a new pathway to cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Targeted mutation of the DNA methyltransferase gene results in embryonic lethality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Molecular basis of base substitution hotspots in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

The CpG dinucleotide and human genetic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

A high easy-to-treat complication rate is the price for continent stoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Accumulation of nuclear p53 and tumor progression in bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

DNA methylation in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

CpG-rich islands and the function of DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

DNA methylation and gene activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Methylation-induced repression--belts, braces, and chromatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

P16 gene in uncultured tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

PAX6 methylation and ectopic expression in human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

E-cadherin involved in inactivation of WNT/beta-catenin signalling in urothelial carcinoma and normal urothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

DNA methylation differences associated with tumor tissues identified by genome scanning analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

COBRA: a sensitive and quantitative DNA methylation assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

DNA methylation analysis by MethyLight technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Tumour class prediction and discovery by microarray-based DNA methylation analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

DNA alterations in body fluids as molecular tumor markers for urological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

Inhibition of DNA methylation and reactivation of silenced genes by zebularine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.07.020

10.1016/J.UROLONC.2006.07.020

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference